Immune suppression: The hallmark of myeloid derived suppressor cells

Immunological Investigations

Volumn 41, Issue 6-7, 2012, Pages 581-594

  Haile, Lydia A ^a,b   Greten, Tim F ^a   Korangy, Firouzeh ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cancer; Tolerance; Tumor immunology

Indexed keywords

ALPHA4 INTEGRIN; CALGRANULIN B; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUOROURACIL; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; GEMCITABINE; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGENIC AGENT;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CULTURAL ANTHROPOLOGY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOREGULATION; KNOCKOUT MOUSE; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SUPPRESSOR CELL; T CELL DEPLETION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MICE; MYELOID PROGENITOR CELLS; NEOPLASM PROTEINS; NEOPLASMS; SPECIES SPECIFICITY; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 84866920846     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.680635     Document Type: Article

References (59)

1. Apolloni, E., Bronte, V., Mazzoni, A., Serafini, P., Cabrelle, A., Segal, D. M., Young, H. A.,Zanovello, P. (2000). Immortalized myeloid suppressor cells trigger apoptosis inantigen-activated T lymphocytes. J. Immunol. 165 (12): 6723-6730.
2. Bronte, V., Serafini, P., Apolloni, E., Zanovello, P. (2001). Tumor-induced immune dysfunctionscaused by myeloid suppressor cells. J Immunother 24 (6): 431-446.
3. Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D.M.,Staib, C., Lowel, M., Sutter, G., Colombo, M. P., Zanovello, P. (2003). IL-4-inducedarginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol 170(1): 270-278.
4. Bronte, V., Wang, M., Overwijk, W.W., Surman, D. R., Pericle, F., Rosenberg, S. A.,Restifo, N. F. (1998). Apoptotic death of CD8 + T lymphocytes after immunization: induction of a suppressive population of Mac-1 +Gr-1 + cells. J. Immunol. 161(10): 5313-5320.
5. Bronte, V., Zanovello, P. (2005). Regulation of immune responses by L-arginine metabolism.Nat. Rev. Immunol. 5 (8): 641-654.
6. Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken,W., Sorg, C., Vogl, T., Roth, J., Gabrilovich, D. I. (2008). Inhibition of dendritic celldifferentiation and accumulation of myeloid-derived suppressor cells in cancer isregulated by S100A9 protein. J. Exp. Med. 205(10): 2235-2249.
7. Corzo, C. A., Condamine, T., Lu, L., Cotter M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis,E., Quiceno, D.G., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich. D. J.(2010). HIF-1alpha regulates function and differentiation of myeloid-derived suppressorcells in the tumor microenvironment. J. Exp. Med. 207(11): 2439-2453.
8. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya,T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2009). Mechanism regulatingreactive oxygen species in tumor-induced myeloid-derived suppressor cells.J. Immunol. 182(9): 5693-5701.
9. Cripps, J. G., and Gorham, J. D. (2011). MDSC in autoimmunity. Int. Immunopharmacol.11 (7): 789-793.
10. De Wilde, V., Van Rompaey, N., Hill, M., Lebrun, J.F., Lemaitre, P., Lhomme, F., Kubjak,C., Vokaer, B., Oldenhove, G., Charbonnier, L. M., Cuturi, M. C., Goldman, M., LeMoine, A. (2009). Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmuneresponses via heme oxygenase-1. Am. J. Transplant 9 (9): 2034-2047.
11. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia,K. M., O'Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., Swan, R., Chung,C. S., Atkinson, M. A., Ramphal, R., Gabrilovich, D. I., Reeves, W. H., Ayala, A.,Phillips, J., Laface, D., Heyworth, P. G., Clare-Salzler, M., Moldawer, L. L. (2007).MyD88-dependent expansion of an immature GR-1( +)CD11b( +) population inducesT cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204 (6): 1463-1474.
12. Dolcetti, L., Peranzoni, E., Bronte, V. (2010). Measurement of myeloid cell immunesuppressive activity. Curr. Protoc. Immunol. Chapter 14: Unit 14-17.
13. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich,M., Winkels, G., Traggiai, E., Casati, A., Grassi, F., Bronte, V. (2010). Hierarchy ofimmunosuppressive strength among myeloid-derived suppressor cell subsets isdetermined by GM-CSF. Eur. J. Immunol. 40(1): 22-35.
14. Dugast, A. S., Haudebourg, T., Coulon, F., Heslan, M., Haspot, F., Poirier, N., Vuillefroyde Silly, R., Usal, C., Smit, H., Martinet, B., Thebault, P., Renaudin, K., Vanhove, B.(2008). Myeloid-derived suppressor cells accumulate in kidney allograft toleranceand specifically suppress effector T cell expansion. J. Immunol. 180 (12): 7898-7906.
15. Fernandez, A., Mesa, C., Marigo, I., Dolcetti, L., Clavell, M., Oliver, L., Fernandez, L. E.,Bronte, V. (2011). Inhibition of tumor-induced myeloid-derived suppressor cell functionby a nanoparticulated adjuvant. J. Immunol. 186: (1): 264-274.
16. Filipazzi, P., V. Huber, L. Rivoltini. 2012. Phenotype, function and clinical implications ofmyeloid-derived suppressor cells in cancer patients. Cancer Immunol. Immunother.61 (2): 255-263.
17. Gabrilovich, D. I., Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators ofthe immune system. Nat. Rev. Immunol. 9(3): 162-174.
18. Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., Kast, W. M. (2001). Mechanism ofimmune dysfunction in cancer mediated by immature Gr-1 + myeloid cells.J. Immunol. 166 (9): 5398-5406.
19. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Basso, G.,Brombacher, F., Borrello, I., Zanovello, P., Bicciato, S., Bronte, V. (2006). Tumorsinduce a subset of inflammatory monocytes with immunosuppressive activity onCD8 + T cells. J. Clin. Invest. 116 (10): 2777-2790.
20. Greten, T. F., Manns, M. P., Korangy, F. (2011). Myeloid derived suppressor cells inhuman diseases. Int. Immunopharmacol. 11 (7): 802-807.
21. Haile, L. A., Gamrekelashvili, J., M., Manns, M. P., Korangy, F., Greten, T. F. (2010).CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulationsin mice. J. Immunol. 185 (1): 203-210.
22. Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Kruger, C., Bachmann, O.,Westendorf, A. M., Buer, J., Liblau, R., Manns, M. P., Korangy, F., Greten, T. F.(2008). Myeloid-derived suppressor cells in inflammatory bowel disease: a newimmunoregulatory pathway. Gastroenterology 135 (3): 871-881, 881 e1-5.
23. Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., and Ostrand-Rosenberg, S.(2009). Myeloid-derived suppressor cells down-regulate L-selectin expression onCD4 + and CD8 + T cells. J. Immunol. 183 (2): 937-944.
24. Hoechst, B., Gamrekelashvili, J., Manns, M. P., Greten, T. F., Korangy, F. (2011).Plasticity of human Th17 cells and iTregs is orchestrated by different subsets ofmyeloid cells. Blood 117 (24): 6532-6541.
25. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten,T. F., Korangy, F. (2008). A new population of myeloid-derived suppressor cells inhepatocellular carcinoma patients induces CD4( +)CD25( +)Foxp3( +) T cells.Gastroenterology 135(1): 234-243.
26. Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer,H., Lehner, F., Manns, M. P., Greten, T. F., Korangy, F. (2009). Myeloid derivedsuppressor cells inhibit natural killer cells in patients with hepatocellular carcinomavia the NKp30 receptor. Hepatology 50(3): 799-807.
27. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., Chen,S. H. (2006). Gr-1 +CD115 + immature myeloid suppressor cells mediate the developmentof tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.Cancer Res. 66 (2): 1123-1131.
28. Kusmartsev, S. A., Li, Y., Chen, S. H. (2000). Gr-1 + myeloid cells derived from tumorbearingmice inhibit primary T cell activation induced through CD3/CD28 costimulation.J. Immunol. 165 (2): 779-785.
29. Kusmartsev, S., Gabrilovich, D. I. (2002). Immature myeloid cells and cancer-associatedimmune suppression. Cancer Immunol. Immunother. 51(6): 293-298.
30. Kusmartsev, S., Nefedova, Y., Yoder, D., Gabrilovich, D. I. (2004). Antigen-specific inhibitionof CD8 + T cell response by immature myeloid cells in cancer is mediated byreactive oxygen species. J. Immunol. 172 (2): 989-999.
31. Le, H. K., Graham, L., Cha, E., Morales, J. K., Manjili, M. H., Bear, H. D. (2009).Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c micebearing 4T1 mammary carcinoma and augments expansion of T cells from tumorbearingmice. Int. Immunopharmacol. 9 (7-8): 900-909.
32. Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., Zhang, H. G. (2007).Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity intumor-bearing host. Blood 109 (10): 4336-4342.
33. Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Pisarev, V.,Sherman, S., Sporn, M. B., and Gabrilovich, D. (2011). Tumor-infiltrating myeloidcells induce tumor cell resistance to cytotoxic T cells in mice. J. Clin. Invest.
34. Makarenkova, V. P., Bansal, V., Matta, B. M., Perez, L. A., Ochoa, J. B. (2006). CD11b +Gr-1 + myeloid suppressor cells cause T cell dysfunction after traumatic stress.J. Immunol. 176 (4): 2085-2094.
35. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S.,Zanon, A., Rossi, C.R., Nitti, D., Bronte, V., Zanovello, P. (2009). IL4Ralpha +myeloidderivedsuppressor cell expansion in cancer patients. J. Immunol. 182 (10): 6562-6528.
36. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N.,Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E.,Mandruzzato, S., Bronte, V. (2010). Tumor-induced tolerance and immune suppressiondepend on the C/EBPbeta transcription factor. Immunity 32 (6): 790-802.
37. Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., and Bronte, V. (2008). Tumor-inducedtolerance and immune suppression by myeloid derived suppressor cells. Immunol.Rev. 222: 162-179.
38. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C.,Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008). Identification ofdiscrete tumor-induced myeloid-derived suppressor cell subpopulations with distinctT cell-suppressive activity. Blood 111(8): 4233-4244.
39. Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L.,Schneck, J., Gabrilovich, D. I. (2007). Altered recognition of antigen is a mechanismof CD8 + T cell tolerance in cancer. Nat. Med. 13(7): 828-835.
40. Nagaraj, S., Nelson, A., Youn, J. L., Cheng, P., Quiceno, D., Gabrilovich, D. I. (2012).Antigen-specific CD4 + T cells regulate function of myeloid-derived suppressor cellsin cancer via retrograde MHC Class II signaling. Cancer Res. 72 (4): 928-938.
41. Nagaraj, S., Schrum, A. G., Cho, H. I., Celis, E., Gabrilovich, D. I. (2010). Mechanism of Tcell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 184(6): 3106-3116.
42. Ostrand-Rosenberg, S. (2010). Myeloid-derived suppressor cells: more mechanisms forinhibiting antitumor immunity. Cancer Immunol. Immunother 59 (10): 1593-1600.
43. Ribechini, E., Leenen, P. J., Lutz, M. B. (2009). Gr-1 antibody induces STAT signaling,macrophage marker expression and abrogation of myeloid-derived suppressor cellactivity in BM cells. Eur. J. Immunol. 39(12): 3538-3551.
44. Serafini, P., Borrello, I., Bronte, V. (2006). Myeloid suppressor cells in cancer: recruitment,phenotype, properties, and mechanisms of immune suppression. Semin.Cancer Biol. 16 (1): 53-65.
45. Serafini, P., Mgebroff, S., Noonan, K., Borrello, I. (2008). Myeloid-derived suppressorcells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.Cancer Res. 68 (13): 5439-5449.
46. Sinha, P., Chornoguz, O., Clements, V. K., Artemenko, K. A., Zubarev, R. A., Ostrand-Rosenberg, S. (2011). Myeloid-derived suppressor cells express the death receptorFas and apoptose in response to T cell-expressed FasL. Blood 117(20): 5381-5390.
47. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., Ostrand-Rosenberg, S. (2007).Cross-talk between myeloid-derived suppressor cells and macrophages subvertstumor immunity toward a type 2 response. J. Immunol. 179(2): 977-983.
48. Solito, S., Bronte, V., Mandruzzato, S. (2011). Antigen specificity of immune suppressionby myeloid-derived suppressor cells. J. Leukoc. Biol. 90(1): 31-36.
49. Stewart, T. J., Smyth, M. J. (2011). Improving cancer immunotherapy by targetingtumor-induced immune suppression. Cancer Metastasis Rev. 30 (1): 125-140.
50. Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., Albelda, S. M. (2005). Gemcitabineselectively eliminates splenic Gr-1 +CD11b + myeloid suppressor cells in tumorbearinganimals and enhances antitumor immune activity. Clin. Cancer Res. 11(18): 6713-6721.
51. Terabe, M., Matsui, S., Park, J. M., Mamura, M., Noben-Trauth, N., Donaldson, D. D.,Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., Letterio, J. J., Paul, W. E., Berzofsky,J. A. (2003). Transforming growth factor-beta production and myeloid cells are aneffector mechanism through which CD1d-restricted T cells block cytotoxic Tlymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.J. Exp. Med. 198 (11): 1741-1752.
52. Ugel, S., Delpozzo, F., Desantis, G., Papalini, F., Simonato, F., Sonda, N., Zilio, S., andBronte, V. (2009). Therapeutic targeting of myeloid-derived suppressor cells. Curr.Opin. Pharmacol. 9(4): 470-481.
53. Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F.,Apetoh, L., Rebe, C., Ghiringhelli, F. (2010). 5-Fluorouracil selectively kills tumorassociatedmyeloid-derived suppressor cells resulting in enhanced T cell-dependentantitumor immunity. Cancer Res. 70 (8): 3052-3061.
54. Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L. H., Cohen, P. A., Shu, S.(2008). Tumor-induced CD11b +Gr-1 + myeloid cells suppress T cell sensitization intumor-draining lymph nodes. J. Immunol. 181(5): 3291-3300.
55. Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian,L. M., Carbone, D. P., Lin, P. C. (2004). Expansion of myeloid immune suppressorGr +CD11b + cells in tumor-bearing host directly promotes tumor angiogenesis.Cancer Cell 6 (4): 409-421.
56. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008). Subsets of myeloid-derivedsuppressor cells in tumor-bearing mice. J. Immunol. 181(8): 5791-5802.
57. Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J.,McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., Mier, J., Ochoa, A. O. (2005).Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: amechanism of tumor evasion. Cancer Res. 65 (8): 3044-3048.
58. Zhao, F., Hoechst, B., Duffy, A., Gamrekelashvili, J., Fioravanti, S., Manns, M. P., Greten,T. P., Korangy, F. (2012). S100A9 a new marker for monocytic human myeloidderived suppressor cells. Immunology.
59. Zhou, R., He, P. L., Ren, Y. X., Wang, W. H., Zhou, R. Y., Wan, H., Ono, S., Fujiwara, H.,Zuo, J. P. (2007). Myeloid suppressor cell-associated immune dysfunction in CSA1Mfibrosarcoma tumor-bearing mice. Cancer Sci. 98 (6): 882-889.